Aptevo shareholders approve reverse stock split (1:5–1:37) and dilutive stock issuance

Aptevo Therapeutics Inc.

Stock issuance and warrant proposal passed (593,301 For, 412,901 Against, 5,355 Abstain).
Reverse stock split approved at ratio of 1-for-5 to 1-for-37; board sets timing and exact ratio.
Adjournment proposal also approved (2,017,270 For, 1,253,171 Against, 9,145 Abstain).
Issuance covers >19.99% of outstanding common stock with price adjustment warrants per Sept 16 agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.